Sequent Scientific Limited (BOM:512529)

Market Cap	47.33B
Revenue (ttm)	15.51B
Net Income (ttm)	218.80M
Shares Out	249.89M
EPS (ttm)	0.85
PE Ratio	222.82
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,894
Average Volume	108,083
Open	191.35
Previous Close	192.25
Day's Range	187.00 - 193.15
52-Week Range	103.95 - 240.90
Beta	1.12
RSI	58.41
Earnings Date	May 21, 2025

About Sequent Scientific

Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics, including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also offers analytical solutions that support API, pharmaceutical, personal care, and nutraceutical organizations; and method validation, stability, and microbiology fo...

• Industry: Pharmaceutical Preparations
• Founded: 1985
• Employees: 1,195
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 512529